US: FDA approves first vaccine to protect newborns from Respiratory Syncytial Virus
First Published: 22nd August, 2023 8:44 IST
The vaccine, made by Pfizer, is given to mothers late in their pregnancies and provides protection to infants through their first six months of life.
The US Food and Drug Administration (FDA) on Monday approved the first vaccine that protects newborns from Respiratory Syncytial Virus (RSV), CNN reported.
The vaccine, made by Pfizer, is given to mothers late in their pregnancies and provides protection to infants through their first six months of life.
In a trial of more than 7,000 pregnant people and their infants, the vaccine, named Abrysvo, cut the risk that infants needed to see a doctor or be admitted to the hospital.
RSV is a common illness and a major cause of hospitalization in infants and the elderly each year. It typically hits hardest during the winter months, and the last RSV season was longer and more severe than usual, overwhelming children’s hospitals.
Director of the FDA’s Center for Biologics Evaluation and Research, Peter Marks in a statement said: “RSV is a common cause of illness in children, and infants are among those at highest risk for severe disease, which can lead to hospitalization.”
“This approval provides an option for healthcare providers and pregnant individuals to protect infants from this potentially life-threatening disease,” he added as per CNN.
As per CNN, there are now several offerings to protect against RSV, including a recently approved antibody shot that can be given to all infants after birth and new vaccines for people 60 and older.
Pfizer’s senior vice president and chief scientific officer for vaccine research and development Annaliesa Anderson said in a statement: “ABRYSVO’s approval as the first and only maternal immunization to help protect newborns immediately at birth through six months from RSV marks a significant milestone for the scientific community and for public health.”
Pfizer has said that maternal vaccination could prevent up to 16,000 hospitalizations and more than 300,000 visits to the doctor due to RSV each year if the vaccine were universally applied. (ANI)
Also Read:
COMMENTS
TOPMOST STORY NOW
Live Brother of BSF Jawan Deepak Chingakham Who Died in Cross-Border Firing by Pakistan in Jammu Appointed ASI in Manipur Police on Compassionate Grounds
11th July 2025
Live Maikhuli Villagers Protest MoU Over Assam-Meghalaya Border, Demand Return of Fishery
11th July 2025
Live Chhangur Baba Received Rs 500 Crore in Foreign Funds for Illegal Conversions: Anti-Terror Squad
11th July 2025
Live Taiwan Detects 9 Chinese Warships, 1 Aircraft Breaching ADIZ Amid Rising Tensions
11th July 2025
WE RECOMMEND
Space Menu Goes Desi: Gajar Ka Halwa Wins Over International Astronauts
The sweet surprise, specially developed for space consumption by ISRO and DRDO, was the centrepiece of a lively gathering aboard Axiom Mission 4.
11th July 2025
“Show Me One Photo of Collateral Damage in OP Sindoor, Operation precise to the point,” NSA, Ajit Doval Dares Foreign Media
National Security Advisor, Ajit Doval on Friday dismissed foreign media reports of collateral damage in India during Operation Sindoor. Hailing Operation Sindoor as a proud moment for India, Doval challenged critics to produce even a single image of destruction of Indian property. Speaking at the 62nd Convocation of IIT Madras, Doval said “Show me even […]
11th July 2025
From Moradabad to Apple HQ: Meet Sabih Khan, the New COO of the iPhone Giant
At Apple, he steadily climbed the ranks and most recently served as the Senior Vice President of Operations.
11th July 2025
Axiom-4 crew, including Group Captain Shubhanshu Shukla, scheduled to undock from ISS on July 14
Axiom Mission 4 was launched on June 25 aboard a SpaceX Falcon 9 rocket from Launch Complex 39A
11th July 2025
Trump announces 35 per cent tariffs on goods imported from Canada
Trump threatened to increase the tariff rate by the same amount if Canada decides to increase their tariffs on importing American products.
11th July 2025